請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/51586
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳世雄(Shih-Hsiung Wu) | |
dc.contributor.author | Juo-Hsin Lai | en |
dc.contributor.author | 賴若馨 | zh_TW |
dc.date.accessioned | 2021-06-15T13:40:01Z | - |
dc.date.available | 2016-02-15 | |
dc.date.copyright | 2016-02-15 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2016-01-14 | |
dc.identifier.citation | 1. Peleg, A. Y., Seifert, H., and Paterson, D. L. (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clinical microbiology reviews 21, 538-582
2. Kim, U. J., Kim, H. K., An, J. H., Cho, S. K., Park, K. H., and Jang, H. C. (2014) Update on the eidemiology, teatment, and outcomes of crbapenem-resistant Acinetobacter infections. Chonnam Med J 50, 37-44 3. Joly-Guillou, M. L. (2005) Clinical impact and pathogenicity of Acinetobacter. Clinical microbiology and infection 11, 868-873 4. Imperi, F., Antunes, L. C., Blom, J., Villa, L., Iacono, M., Visca, P., and Carattoli, A. (2011) The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life 63, 1068-1074 5. Visca, P., Seifert, H., and Towner, K. J. (2011) Acinetobacter infection--an emerging threat to human health. IUBMB Life 63, 1048-1054 6. Camp, C., and Tatum, O. L. (2010) A Review of Acinetobacter baumannii as a highly successful pathogen in times of war. Labmedicine 41, 649-657 7. McConnell, M. J., Actis, L., and Pachon, J. (2013) Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev 37, 130-155 8. Levin, A. S., Levy, C. E., Manrique, A. E., Medeiros, E. A., and Costa, S. F. (2003) Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents 21, 58-62 9. Cerqueira, G. M., and Peleg, A. Y. (2011) Insights into Acinetobacter baumannii pathogenicity. Iubmb Life 63, 1055-1060 10. Al-Anazi, K. A., and Al-Jasser, A. M. (2014) Infections caused by Acinetobacter baumannii in recipients of hematopoietic stem cell transplantation. Front Oncol 4, 186 11. Kassamali, Z., Jain, R., and Danziger, L. H. (2015) An Update on the arsenal for multidrug-resistant Acinetobacter infections: Polymyxin antibiotics. International journal of infectious diseases 30C, 125-132 12. Manchanda, V., Sanchaita, S., and Singh, N. (2010) Multidrug resistant acinetobacter. J Glob Infect Dis 2, 291-304 13. Cayo, R., Rodriguez, M. C., Espinal, P., Fernandez-Cuenca, F., Ocampo-Sosa, A. A., Pascual, A., Ayala, J. A., Vila, J., and Martinez-Martinez, L. (2011) Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii. Antimicrobial agents and chemotherapy 55, 5907-5913 14. Smith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., and Snyder, M. (2007) New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21, 601-614 15. Karaiskos, I., and Giamarellou, H. (2014) Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert opinion on pharmacotherapy 15, 1351-1370 16. Alekshun, M. N., and Levy, S. B. (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128, 1037-1050 17. Tang, S. S., Apisarnthanarak, A., and Hsu, L. Y. (2014) Mechanisms of beta-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria. Adv Drug Deliv Rev 78, 3-13 18. Liang-Yu, C., Kuo, S. C., Liu, C. Y., Luo, B. S., Huang, L. J., Lee, Y. T., Chen, C. P., Chen, T. L., and Fung, C. P. (2011) Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007. J Microbiol Immunol Infect 44, 358-363 19. Poirel, L., Bonnin, R. A., and Nordmann, P. (2011) Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 63, 1061-1067 20. Corvec, S., Caroff, N., Espaze, E., Giraudeau, C., Drugeon, H., and Reynaud, A. (2003) AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 52, 629-635 21. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D. L., Rice, L. B., Stelling, J., Struelens, M. J., Vatopoulos, A., Weber, J. T., and Monnet, D. L. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection 18, 268-281 22. Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., and Bonomo, R. A. (2011) Carbapenems: past, present, and future. Antimicrobial agents and chemotherapy 55, 4943-4960 23. Huang, S. T., Chiang, M. C., Kuo, S. C., Lee, Y. T., Chiang, T. H., Yang, S. P., Ti, Y., Chen, T. L., and Fung, C. P. (2012) Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 45, 356-362 24. Karaoglan, I., Zer, Y., Bosnak, V. K., Mete, A. O., and Namiduru, M. (2013) In vitro synergistic activity of colistin with tigecycline or beta-lactam antibiotic/beta-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. J Int Med Res 41, 1830-1837 25. Tiwari, V., and Tiwari, M. (2014) Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii. Front Microbiol 5, 512 26. Baran, G., Erbay, A., Bodur, H., Onguru, P., Akinci, E., Balaban, N., and Cevik, M. A. (2008) Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. International journal of infectious diseases 12, 16-21 27. Su, C. H., Wang, J. T., Hsiung, C. A., Chien, L. J., Chi, C. L., Yu, H. T., Chang, F. Y., and Chang, S. C. (2012) Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 7, e37788 28. Beadle, B. M., and Shoichet, B. K. (2002) Structural basis for imipenem inhibition of class C β-lactamases. Antimicrobial agents and chemotherapy 46, 3978-3980 29. Trehan, I., Beadle, B. M., and Shoichet, B. K. (2001) Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site. Biochemistry 40, 7992-7999 30. Kuo, H. Y., Chang, K. C., Kuo, J. W., Yueh, H. W., and Liou, M. L. (2012) Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii. Int J Antimicrob Agents 39, 33-38 31. Lee, M. H., Chen, T. L., Lee, Y. T., Huang, L., Kuo, S. C., Yu, K. W., Hsueh, P. R., Dou, H. Y., Su, I. J., and Fung, C. P. (2013) Dissemination of multidrug-resistant Acinetobacter baumannii carrying blaOxA-23 from hospitals in central Taiwan. J Microbiol Immunol Infect 46, 419-424 32. Lee, H. Y., Chen, C. L., Wang, S. B., Su, L. H., Chen, S. H., Liu, S. Y., Wu, T. L., Lin, T. Y., and Chiu, C. H. (2011) Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents 37, 302-308 33. Owens, R. C., Jr., and Rice, L. (2006) Hospital-based strategies for combating resistance. Clinical infectious diseases 42, S173-181 34. Gordon, N. C., and Wareham, D. W. (2010) Multidrug resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 35, 219-226 35. Elabd, F. M., Al-Ayed, M. S., Asaad, A. M., Alsareii, S. A., Qureshi, M. A., and Musa, H. A. (2015) Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital. Journal of infection and public health 8, 242-247 36. Drawz, S. M., and Bonomo, R. A. (2010) Three decades of beta-lactamase inhibitors. Clinical microbiology reviews 23, 160-201 37. Brook, I. (2009) The role of beta-lactamase-producing-bacteria in mixed infections. BMC infectious diseases 9, 202 38. Di Conza, J. A., Badaracco, A., Ayala, J., Rodriguez, C., Famiglietti, Á., and Gutkind, G. O. (2014) β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: A new blaTEM gene. Revista Argentina de Microbiología 46, 210-217 39. Bhattacharya, M., Toth, M., Antunes, N. T., Smith, C. A., and Vakulenko, S. B. (2014) Structure of the extended-spectrum class C beta-lactamase ADC-1 from Acinetobacter baumannii. Acta Crystallogr D Biol Crystallogr 70, 760-771 40. Galleni, M., Amicosante, G., and Frere, J. M. (1988) A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds. Biochem J 255, 123-129 41. Jacoby, G. A. (2009) AmpC beta-lactamases. Clin Microbiol Rev 22, 161-182 42. Hamidian, M., and Hall, R. M. (2014) Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii. J Antimicrob Chemother 69, 77-80 43. Rodriguez-Martinez, J. M., Poirel, L., and Nordmann, P. (2010) Genetic and functional variability of AmpC-type beta-lactamases from Acinetobacter baumannii. Antimicrobial agents and chemotherapy 54, 4930-4933 44. Tiwari, V., Vashistt, J., Kapil, A., and Moganty, R. R. (2012) Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS One 7, e39451 45. Quale, J., Bratu, S., Landman, D., and Heddurshetti, R. (2003) Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clinical infectious diseases 37, 214-220 46. Beadle, B. M., and Shoichet, B. K. (2002) Structural bases of stability–function tradeoffs in enzymes. Journal of Molecular Biology 321, 285-296 47. Grangeasse, C., Stulke, J., and Mijakovic, I. (2015) Regulatory potential of post-translational modifications in bacteria. Frontiers in microbiology 6, 500 48. Huang, Y. W., Wu, C. J., Hu, R. M., Lin, Y. T., and Yang, T. C. (2015) Interplay among membrane-bound lytic transglycosylase D1, the CreBC two-component regulatory system, the AmpNG-AmpDI-NagZ-AmpR regulatory circuit, and L1/L2 beta-lactamase expression in Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy 59, 6866-6872 49. Muller, C., Plesiat, P., and Jeannot, K. (2011) A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and beta-lactams in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 55, 1211-1221 50. Udo, H., Munoz-Dorado, J., Inouye, M., and Inouye, S. (1995) Myxococcus xanthus, a gram-negative bacterium, contains a transmembrane protein serine/threonine kinase that blocks the secretion of beta-lactamase by phosphorylation. Genes & Development 9, 972-983 51. Macek, B., Gnad, F., Soufi, B., Kumar, C., Olsen, J. V., Mijakovic, I., and Mann, M. (2008) Phosphoproteome analysis of E. coli reveals evolutionary conservation of bacterial Ser/Thr/Tyr phosphorylation. Mol Cell Proteomics 7, 299-307 52. Soares, N. C., Spat, P., Mendez, J. A., Nakedi, K., Aranda, J., and Bou, G. (2014) Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate. Journal of proteomics 102, 113-124 53. Cousin, C., Derouiche, A., Shi, L., Pagot, Y., Poncet, S., and Mijakovic, I. (2013) Protein-serine/threonine/tyrosine kinases in bacterial signaling and regulation. FEMS Microbiol Lett 346, 11-19 54. Imamura, H., Wakabayashi, M., and Ishihama, Y. (2012) Analytical strategies for shotgun phosphoproteomics: status and prospects. Semin Cell Dev Biol 23, 836-842 55. Kobir, A., Shi, L., Boskovic, A., Grangeasse, C., Franjevic, D., and Mijakovic, I. (2011) Protein phosphorylation in bacterial signal transduction. Biochim Biophys Acta 1810, 989-994 56. Cozzone, A. J. (2012) An insight into future antibacterial therapy. Emerging Microbes & Infections 1, e38 57. Ouidir, T., Jarnier, F., Cosette, P., Jouenne, T., and Hardouin, J. (2014) Potential of liquid-isoelectric-focusing protein fractionation to improve phosphoprotein characterization of Pseudomonas aeruginosa PA14. Analytical and bioanalytical chemistry 406, 6297-6309 58. Ravichandran, A., Sugiyama, N., Tomita, M., Swarup, S., and Ishihama, Y. (2009) Ser/Thr/Tyr phosphoproteome analysis of pathogenic and non-pathogenic Pseudomonas species. Proteomics 9, 2764-2775 59. Misra, S. K., Milohanic, E., Ake, F., Mijakovic, I., Deutscher, J., Monnet, V., and Henry, C. (2011) Analysis of the serine/threonine/tyrosine phosphoproteome of the pathogenic bacterium Listeria monocytogenes reveals phosphorylated proteins related to virulence. Proteomics 11, 4155-4165 60. Prisic, S., Dankwa, S., Schwartz, D., Chou, M. F., Locasale, J. W., Kang, C. M., Bemis, G., Church, G. M., Steen, H., and Husson, R. N. (2010) Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases. Proc Natl Acad Sci U S A 107, 7521-7526 61. Ge, R., Sun, X., Xiao, C., Yin, X., Shan, W., Chen, Z., and He, Q. Y. (2011) Phosphoproteome analysis of the pathogenic bacterium Helicobacter pylori reveals over-representation of tyrosine phosphorylation and multiply phosphorylated proteins. Proteomics 11, 1449-1461 62. Sun, X., Ge, F., Xiao, C. L., Yin, X. F., Ge, R., Zhang, L. H., and He, Q. Y. (2010) Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae. Journal of proteome research 9, 275-282 63. Voisin, S., Watson, D. C., Tessier, L., Ding, W., Foote, S., Bhatia, S., Kelly, J. F., and Young, N. M. (2007) The cytoplasmic phosphoproteome of the Gram-negative bacterium Campylobacter jejuni: evidence for modification by unidentified protein kinases. Proteomics 7, 4338-4348 64. Basell, K., Otto, A., Junker, S., Zuhlke, D., Rappen, G. M., Schmidt, S., Hentschker, C., Macek, B., Ohlsen, K., Hecker, M., and Becher, D. (2014) The phosphoproteome and its physiological dynamics in Staphylococcus aureus. International journal of medical microbiology 304, 121-132 65. Lin, M. H., Hsu, T. L., Lin, S. Y., Pan, Y. J., Jan, J. T., Wang, J. T., Khoo, K. H., and Wu, S. H. (2009) Phosphoproteomics of Klebsiella pneumoniae NTUH-K2044 reveals a tight link between tyrosine phosphorylation and virulence. Mol Cell Proteomics 8, 2613-2623 66. Hu, C. W., Lin, M. H., Huang, H. C., Ku, W. C., Yi, T. H., Tsai, C. F., Chen, Y. J., Sugiyama, N., Ishihama, Y., Juan, H. F., and Wu, S. H. (2012) Phosphoproteomic analysis of Rhodopseudomonas palustris reveals the role of pyruvate phosphate dikinase phosphorylation in lipid production. Journal of proteome research 11, 5362-5375 67. Wu, W. L., Liao, J. H., Lin, G. H., Lin, M. H., Chang, Y. C., Liang, S. Y., Yang, F. L., Khoo, K. H., and Wu, S. H. (2013) Phosphoproteomic analysis reveals the effects of PilF phosphorylation on type IV pilus and biofilm formation in Thermus thermophilus HB27. Mol Cell Proteomics 12, 2701-2713 68. Beltramini, A. M., Mukhopadhyay, C. D., and Pancholi, V. (2009) Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase. Infect Immun 77, 1406-1416 69. Kurabayashi, K., Hirakawa, Y., Tanimoto, K., Tomita, H., and Hirakawa, H. (2014) Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake. J Bacteriol 196, 248-256 70. Boudreau, M. A., Fishovitz, J., Llarrull, L. I., Xiao, Q., and Mobashery, S. (2015) Phosphorylation of BlaR1 in manifestation of antibiotic resistance in methicillin-resistant Staphylococcus aureus and its abrogation by small molecules. ACS Infectious Diseases 1, 454-459 71. Mijakovic, I., and Macek, B. (2012) Impact of phosphoproteomics on studies of bacterial physiology. FEMS Microbiol Rev 36, 877-892 72. Wang, F., Song, C., Cheng, K., Jiang, X., Ye, M., and Zou, H. (2011) Perspectives of comprehensive phosphoproteome analysis using shotgun strategy. Anal Chem 83, 8078-8085 73. Yang, M. K., Qiao, Z. X., Zhang, W. Y., Xiong, Q., Zhang, J., Li, T., Ge, F., and Zhao, J. D. (2013) Global phosphoproteomic analysis reveals diverse functions of serine/threonine/tyrosine phosphorylation in the model Cyanobacterium Synechococcus sp. strain PCC 7002. Journal of proteome research 12, 1909-1923 74. Chen, T. L., Lee, Y. T., Kuo, S. C., Hsueh, P. R., Chang, F. Y., Siu, L. K., Ko, W. C., and Fung, C. P. (2010) Emergence and distribution of plasmids bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrobial agents and chemotherapy 54, 4575-4581 75. Lee, Y. T., Kuo, S. C., Chiang, M. C., Yang, S. P., Chen, C. P., Chen, T. L., and Fung, C. P. (2012) Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrobial agents and chemotherapy 56, 1124-1127 76. Okonechnikov, K., Golosova, O., Fursov, M., and team, U. (2012) Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics 28, 1166-1167 77. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2, 1896-1906 78. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., and Mann, M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 79. Aziz, R. K., Bartels, D., Best, A. A., DeJongh, M., Disz, T., Edwards, R. A., Formsma, K., Gerdes, S., Glass, E. M., Kubal, M., Meyer, F., Olsen, G. J., Olson, R., Osterman, A. L., Overbeek, R. A., McNeil, L. K., Paarmann, D., Paczian, T., Parrello, B., Pusch, G. D., Reich, C., Stevens, R., Vassieva, O., Vonstein, V., Wilke, A., and Zagnitko, O. (2008) The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9, 75 80. Yu, N. Y., Wagner, J. R., Laird, M. R., Melli, G., Rey, S., Lo, R., Dao, P., Sahinalp, S. C., Ester, M., Foster, L. J., and Brinkman, F. S. (2010) PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26, 1608-1615 81. Chen, T. L., Wu, R. C., Shaio, M. F., Fung, C. P., and Cho, W. L. (2008) Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrobial agents and chemotherapy 52, 2573-2580 82. Kuo, S. C., Yang, S. P., Lee, Y. T., Chuang, H. C., Chen, C. P., Chang, C. L., Chen, T. L., Lu, P. L., Hsueh, P. R., and Fung, C. P. (2013) Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in Taiwan. BMC Infect Dis 13, 319 83. Liao, Y. T., Kuo, S. C., Lee, Y. T., Chen, C. P., Lin, S. W., Shen, L. J., Fung, C. P., Cho, W. L., and Chen, T. L. (2014) Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection. Antimicrobial agents and chemotherapy 58, 3983-3990 84. Chiu, J., March, P. E., Lee, R., and Tillett, D. (2004) Site-directed, Ligase-Independent Mutagenesis (SLIM): a single-tube methodology approaching 100% efficiency in 4 h. Nucleic acids research 32, e174 85. Mammeri, H., Poirel, L., and Nordmann, P. (2007) Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J Antimicrob Chemother 60, 490-494 86. Chen, T. L., Chang, W. C., Kuo, S. C., Lee, Y. T., Chen, C. P., Siu, L. K., Cho, W. L., and Fung, C. P. (2010) Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU. Antimicrobial agents and chemotherapy 54, 3107-3112 87. Kim, S. H., and Wei, C. I. (2007) Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities. J Appl Microbiol 103, 400-408 88. Ishihama, Y., Wei, F. Y., Aoshima, K., Sato, T., Kuromitsu, J., and Oda, Y. (2007) Enhancement of the efficiency of phosphoproteomic identification by removing phosphates after phosphopeptide enrichment. Journal of proteome research 6, 1139-1144 89. Minond, D., Saldanha, S. A., Subramaniam, P., Spaargaren, M., Spicer, T., Fotsing, J. R., Weide, T., Fokin, V. V., Sharpless, K. B., Galleni, M., Bebrone, C., Lassaux, P., and Hodder, P. (2009) Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries. Bioorg Med Chem 17, 5027-5037 90. Tsang, M. W., and Leung, Y. C. (2007) Overexpression of the recombinant Enterobacter cloacae P99 AmpC beta-lactamase and its mutants based on a phi105 prophage system in Bacillus subtilis. Protein Expr Purif 55, 75-83 91. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta crystallographica. Section D, Biological crystallography 60, 2126-2132 92. Takahata, Y., Inoue, M., Kim, K., Iio, Y., Miyamoto, M., Masui, R., Ishihama, Y., and Kuramitsu, S. (2012) Close proximity of phosphorylation sites to ligand in the phosphoproteome of the extreme thermophile Thermus thermophilus HB8. Proteomics 12, 1414-1430 93. Whitmore, S. E., and Lamont, R. J. (2012) Tyrosine phosphorylation and bacterial virulence. Int J Oral Sci 4, 1-6 94. Bonomo, R. A., and Szabo, D. (2006) Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clinical infectious diseases 43, S49-56 95. Chen, Y., McReynolds, A., and Shoichet, B. K. (2009) Re-examining the role of Lys67 in class C beta-lactamase catalysis. Protein science 18, 662-669 96. Chen, Y., Minasov, G., Roth, T. A., Prati, F., and Shoichet, B. K. (2006) The deacylation mechanism of AmpC beta-lactamase at ultrahigh resolution. Journal of the American Chemical Society 128, 2970-2976 97. Goldberg, S. D., Iannuccilli, W., Nguyen, T., Ju, J., and Cornish, V. W. (2003) Identification of residues critical for catalysis in a class C beta-lactamase by combinatorial scanning mutagenesis. Protein science 12, 1633-1645 98. Thomas, V. L., McReynolds, A. C., and Shoichet, B. K. (2010) Structural bases for stability-function tradeoffs in antibiotic resistance. J Mol Biol 396, 47-59 99. Birck, C., Mourey, L., Gouet, P., Fabry, B., Schumacher, J., Rousseau, P., Kahn, D., and Samama, J. P. (1999) Conformational changes induced by phosphorylation of the FixJ receiver domain. Structure 7, 1505-1515 100. Ciarimboli, G., Koepsell, H., Iordanova, M., Gorboulev, V., Durner, B., Lang, D., Edemir, B., Schroter, R., Van Le, T., and Schlatter, E. (2005) Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation. J Am Soc Nephrol 16, 1562-1570 101. Mehrens, T., Lelleck, S., Cetinkaya, I., Knollmann, M., Hohage, H., Gorboulev, V., Boknik, P., Koepsell, H., and Schlatter, E. (2000) The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. Journal of the American Society of Nephrology 11, 1216-1224 102. Singh, J., Petter, R. C., Baillie, T. A., and Whitty, A. (2011) The resurgence of covalent drugs. Nat Rev Drug Discov 10, 307-317 103. Lin, M. F., Lin, Y. Y., Yeh, H. W., and Lan, C. Y. (2014) Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility. BMC Microbiol 14, 119 104. Hirakawa, H., Nishino, K., Yamada, J., Hirata, T., and Yamaguchi, A. (2003) Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Antimicrob Chemother 52, 576-582 105. Antunes, L. C., Imperi, F., Carattoli, A., and Visca, P. (2011) Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6, e22674 106. Smani, Y., McConnell, M. J., and Pachon, J. (2012) Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells. PLoS One 7, e33073 107. Devos, S., Van Oudenhove, L., Stremersch, S., Van Putte, W., De Rycke, R., Van Driessche, G., Vitse, J., Raemdonck, K., and Devreese, B. (2015) The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Frontiers in microbiology 6, 298 108. Choi, A. H., Slamti, L., Avci, F. Y., Pier, G. B., and Maira-Litran, T. (2009) The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 191, 5953-5963 109. Abbott, I., Cerqueira, G. M., Bhuiyan, S., and Peleg, A. Y. (2013) Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev Anti Infect Ther 11, 395-409 110. Fernandez, L., and Hancock, R. E. (2012) Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev 25, 661-681 111. Hou, P. F., Chen, X. Y., Yan, G. F., Wang, Y. P., and Ying, C. M. (2012) Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of Acinetobacter baumannii. Chemotherapy 58, 152-158 112. Srinivasan, V. B., Rajamohan, G., Pancholi, P., Marcon, M., and Gebreyes, W. A. (2011) Molecular cloning and functional characterization of two novel membrane fusion proteins in conferring antimicrobial resistance in Acinetobacter baumannii. J Antimicrob Chemother 66, 499-504 113. Russo, T. A., MacDonald, U., Beanan, J. M., Olson, R., MacDonald, I. J., Sauberan, S. L., Luke, N. R., Schultz, L. W., and Umland, T. C. (2009) Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. J Infect Dis 199, 513-521 114. Gehrlein, M., Leying, H., Cullmann, W., Wendt, S., and Opferkuch, W. (1991) Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins. Chemotherapy 37, 405-412 115. Bornet, C., Chollet, R., Mallea, M., Chevalier, J., Davin-Regli, A., Pages, J. M., and Bollet, C. (2003) Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochemical and Biophysical Research Communications 301, 985-990 116. Fischer, N., and Kandt, C. (2013) Porter domain opening and closing motions in the multi-drug efflux transporter AcrB. Biochim Biophys Acta 1828, 632-641 117. Pradel, E., and Pages, J. M. (2002) The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrobial agents and chemotherapy 46, 2640-2643 118. Woodhams, K. L., Chan, J. M., Lenz, J. D., Hackett, K. T., and Dillard, J. P. (2013) Peptidoglycan fragment release from Neisseria meningitidis. Infect Immun 81, 3490-3498 119. Yang, T. C., Chen, T. F., Tsai, J. J., and Hu, R. M. (2014) NagZ is required for beta-lactamase expression and full pathogenicity in Xanthomonas campestris pv. campestris str. 17. Res Microbiol 165, 612-619 120. Kong, K. F., Aguila, A., Schneper, L., and Mathee, K. (2010) Pseudomonas aeruginosa beta-lactamase induction requires two permeases, AmpG and AmpP. BMC Microbiol 10, 328 121. Everett, M., Walsh, T., Guay, G., and Bennett, P. (1995) Gcva, a Lysr-type transcriptional regulator protein, activates expression of the cloned Citrobacter Freundii Ampc Beta-lactamase gene in Escherichia Coli cross-talk between DNA-binding proteins. Microbiology-Uk 141, 419-430 122.Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., O'Kelly, G., Schoenegger, A., Ovelleiro, D., Perez-Riverol, Y., Reisinger, F., Rios, D., Wang, R., and Hermjakob, H. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic acids research 41, D1063-1069 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/51586 | - |
dc.description.abstract | 鮑氏不動桿菌(Acinetobacter baumannii)為一伺機性致病菌,已知會感染住院、免疫力低下、及患病末期的病人。重要的是,具多重抗藥性的鮑氏不動桿菌(multidrug resistant Acinetobacter baumannii ,簡稱 MDRAB)的出現已導致此菌演變成高毒性的院內致病菌,且是引起院內感染大爆發的原因。全球散布的MDRAB已經對人類健康造成嚴重的威脅,尤其是近十年大量對抗生素碳青黴烯
(carbapenem)產生抗性的菌株出現。在許多的碳青黴烯衍生物之中,亞胺培南(imipenem)能有效的對抗鮑氏不動桿菌。在西元1990 年代初期,已有報導指出鮑氏不動桿菌已對亞胺培南產生抗性,然而參與其中的分子機制還不明朗。從細菌到人類,蛋白質的翻譯後修飾作用廣見於各類物種。其中,磷酸化是一種可逆的蛋白質的轉譯後修飾作用,且與多種的細胞、代謝、訊息傳導的過程相關。 研究病源菌的磷酸化蛋白質體學可提供一個系統性的觀察,以探討磷酸化蛋白在致病的調控中所扮演的角色。在本研究中,我們分析了兩株臨床鮑氏不動桿菌株;亞胺培南敏感性的菌株SK17-S,及對亞胺培南產生抗性的菌株SK17-R。從散彈式策略以及高解析度的質譜儀偵測實驗中,於SK17-S 樣本中找出248 個磷酸化蛋白及410 個磷酸化位置,其胺基酸分布為47.0:27.6:12.4:8.0:4.9%於絲胺酸/蘇胺酸/酪胺酸/天門冬胺酸/組胺酸。此外於SK17-R 樣本中找出211 個磷酸化蛋白及285 個磷酸化位置,其絲胺酸/蘇胺酸/酪胺酸/天門冬胺酸/組胺酸分布則為41.4:29.5:17.5:6.7:4.9%。其中首次在SK17-S 樣本裡發現,一種乙內醯胺酶AmpC的絲胺酸第九十號(Ser-90)位置上有被磷酸化修飾,且此第九十號絲胺酸就位在此酵素的催化結構域 (S88VS90K) 上。因此,我們假設AmpC 蛋白磷酸化可能調控乙內醯胺酶的活性,與中和抵銷亞胺培南抗生素的能力。透過點突變的實驗 方法,我們發現模擬Ser-90 去磷酸化的轉殖株 (S90A)對imipenem 產生較高的抗性,相反地,模擬Ser-90 磷酸化的轉殖株 (S90D) 則是對imipenem 敏感的。並且S90A 突變蛋白的乙內醯胺酶活性較強,藉由與imipene 更結合並賦予菌株SK17-S 更多的保護力去對抗imipenem,且保護力是優於原生(wild-type)的AmpC。總結本研究結果顯示,在鮑氏不動桿菌的乙內醯胺酶AmpC 上Ser-90 的磷酸化,可負向的調控鮑氏不動桿菌對imipenem 的感受性、乙內醯胺酶活性、 及中和抵銷imipenem 抗生素的效應。 | zh_TW |
dc.description.abstract | Acinetobacter baumannii is an opportunistic bacterial pathogen which is known to infect hospitalized, immunocompromised, or terminal patients. Importantly, this bacterium has become a high-virulent nosocomial pathogen due to the emergence of multidrug-resistant Acinetobacter baumannii (MDRAB) responsible for numerous outbreaks of infections. Global spread of MDRAB has emerged as a serious threat to human health; especially carbapenem resistance has greatly increased over recent decades. Among the many carbapenem derivatives, imipenem has been found to be effective against A. baumannii. It has been reported that imipenem resistance in A. baumannii threatens human health since the early 1990s; however, the underlying molecular mechanisms remain unclear. Accordingly, post-translational modifications (PTMs) of proteins have been found in a wide variety of species from bacteria to human. Among all, phosphorylation is a kind of reversible PTMs, and has been linked to a wide variety of cellular, metabolic, and signaling processes. Measuring the phosphoproteomics of pathogenic bacteria can provide a system view for investigating their roles in virulence regulation networks. In this study, we analyzed the phosphoproteomics of two clinical isolates of A. baumannii: imipenem-sensitive strain SK17-S and -resistant strain SK17-R. Using a shotgun strategy combined with high-accuracy mass spectrometry, we identified 410 phosphosites on 248 unique phosphoproteins from SK17-S and 285 phosphosites on 211 unique phosphoproteins from SK17-R. The distributions of the Ser/Thr/Tyr/Asp/His phosphosites from SK17-S and SK17-R are 47.0, 27.6, 12.4, 8.0, and 4.9% versus 41.4, 29.5, 17.5, 6.7, and 4.9%, respectively. Among all, the Ser-90 phosphosite, located on the catalytic motif S88VS90K91 of the AmpC β-lactamase, was first identified from SK17-S. We hypothesized that AmpC phosphorylation may control its enzyme activity and the ability of neutralizing imipenem due to the proximity of Ser-90 to the catalytic residue Ser-88. By site-directed mutagenesis, the nonphosphorylatable strain S90A was more resistant to imipenem, by contrast, the phosphorylation-simulated strain S90D was imipenem-sensitive. Also, S90A mutant protein exhibited higher β-lactamase activity and conferred more bacterial protection on SK17-S against imipenem than the wild-type. In summary, our results revealed that in A. baumannii Ser-90 phosphorylation of AmpC negatively regulates both β-lactamase activity and the ability to counteract the antibiotic effects of imipenem. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T13:40:01Z (GMT). No. of bitstreams: 1 ntu-104-D98b46004-1.pdf: 54446211 bytes, checksum: 937bf015f0d4b31e7a8a2df2692d8b08 (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 謝誌_i
中文摘要_ii 英文摘要_iv 目錄_vi Abbreviations_xii List of Figures_xiii List of Tables_xvi Chapter 1: Introduction_1 1.1. General introduction of Acinetobacter baumannii_1 1.2. Clinical impact and pathogenicity of Acinetobacter baumannii_2 1.3. The emergence of multidrug-resistant Acinetobacter baumannii_4 1.4. Outbreaks of carbapenem-resistant Acinetobacter baumannii_5 1.5. The potential virulence factors involving in imipenem resistance_7 1.6. β-lactamase-mediated multidrug-resistance in Acinetobacter baumannii_9 1.7. The roles of β-lactamase phosphorylation in bacteria_11 1.8. Phosphoproteomic analysis of pathogenic bacteria_12 1.9. The impact of protein phosphorylation in antibiotic resistance_13 1.10. Aims and experimental designs_15 Chapter 2: Materials and Methods 2.1 Bacterial strains growth conditions_16 2.2 DNA sequencing and database generation_17 2.3 Protein extraction and Western blot analysis_18 2.4 In-solution protein digestion and phosphopeptide enrichment_19 2.5 NanoLC-MS/MS Analysis_20 2.6 Data validation and classification_22 2.7 Homology modeling_23 2.8 Construction of AmpC expression plasmids and site-directed mutagenesis_24 2.9 Electrotransformation of plasmid-borne ISAba1-AmpC_26 2.10 Antibiotic resistance profiles and identification_27 2.11 Purification of AmpC and mutant proteins_28 2.12 Circular dichroism (CD) spectra_29 2.13 β-lactamase assay and kinetic parameters_29 2.14 Neutralization of imipenem by purified AmpCs_30 2.15 Docking experiments_31 Chapter 3: Results Part 1 3.1.1 Phosphoproteomic analysis of Acinetobacter baumannii SK17-S and SK17-R_32 3.1.2 Classification of the identified phosphoproteins_35 3.1.3 The identified phosphosites form AmpC β-lactamase in the category of virulence disease and defense_39 Part 2 3.2.1 Effects of site-directed mutagenesis of AmpC on antibiotics susceptibility_43 3.2.2 Effect of AmpC Ser-90 phosphorylation on β-lactamase activity and the ability to neutralize imipenem_46 3.2.3 Docking of imipenem on AmpC and mutant proteins_51 Chapter 4: Discussion 4.1 Comparison of phosphoproteins identified from Acinetobacter baumannii SK17-S and SK17-R_57 4.2 The identified phosphoproteins correlated to imipenem resistance_58 4.3 Effects of AmpC Ser-90 phosphorylation on antibiotic profiles, β-lactamase activity, and the ability to neutralize imipenem_61 4.4 Docking calculations reveal the steric hindrance due to AmpC Ser-90 phosphorylation_62 Chapter 5: Perspective_64 Acknowledgments_65 Reference_66 Appendix 1. _77 Detailed information on the phosphoproteins, phosphopeptides, and phosphorylation sites detected in A. baumannii strain SK17-S. Appendix 2. _91 Detailed information on the phosphoproteins, phosphopeptides, and phosphorylation sites detected in A. baumannii strain SK17-R. Appendix 3. _101 Overlapping and unique phosphoproteins detected in A. baumannii strains SK17-S and SK17-R. Appendix 4. _106 Comparison of the results of the phosphoproteomics of four strains of A. baumannii. Appendix 5. _108 Phosphoproteins from A. baumannii strains SK17-S and SK17-R assigned to the functional category of transport and binding proteins (TBP). Appendix 6. _110 Phosphoproteins from A. baumannii strains SK17-S and SK17-R assigned to the functional category of virulence, disease, and defense (VDD). Appendix 7. _112 The antibiotic susceptibility of AmpC transformants containing Ser-81 or/and Ser-90 mutations in AmpC. Appendix 8. _113 The antibiotic susceptibility of AmpC transformants containing Ser-88 or/and Ser-90 mutations in AmpC. Appendix 9. _114 Detection of imipenem susceptibility of A. baumannii SK17-S in the presence of recombinant AmpCs by neutralization assay. | |
dc.language.iso | en | |
dc.title | 以磷酸化蛋白質體學研究鮑氏不動桿菌臨床菌株SK17中磷酸化對乙內醯胺酶AmpC活性的調控機制 | zh_TW |
dc.title | Comparative phosphoproteomics reveals the role of AmpC β-lactamase phosphorylation in the clinical imipenem-resistant strain Acinetobacter baumannii SK17 | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 梁博煌(Po-Huang Liang),張文章(Wen-Chang Chang),陳德禮(Te-Li Chen),邱繼輝(Kay-Hooi Khoo),花國鋒(Kuo-Feng Hua) | |
dc.subject.keyword | 多重抗藥性的鮑氏不動桿菌,亞胺培南,磷酸化蛋白質體學,質譜儀分析儀,二氧化鈦萃取磷酸化胜?,乙內醯胺?AmpC, | zh_TW |
dc.subject.keyword | multidrug-resistant Acinetobacter baumannii,imipenem,phosphoproteome,Mass spectrometry,TiO2 phosphopeptide enrichment,AmpC β-lactamase, | en |
dc.relation.page | 114 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-01-15 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科學研究所 | zh_TW |
顯示於系所單位: | 生化科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 53.17 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。